• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

6
5
5
5
2

COUNTRY

1
1
1
1
1

CATEGORIES

  • 11
  • 4
  • 1
  • 1
  • 1
  • 1

PRICE

1
2
5
15

PUBLISHED

0
0
2
15

PRODUCT TYPE

15

Search "YM BioSciences Inc.-Therapeutic Competitors Report" returned 15 results.

PRODUCT TITLE
Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing pancreatic cancer drug development Find out whether you are number one, two or further down the ladder...

March 2012
FROM
A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market - Product Thumbnail Image

A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market

This report comprises defined and up to date development strategies for 347 colorectal cancer drugs within the portfolio of 182 companies, from Ceased to Marketed The report extensively analyses their...

March 2011
FROM

Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020” The report is an essential...

December 2010
FROM

Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020” The report is an essential...

December 2010
FROM

Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020” is an essential source...

December 2010
FROM

Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020” is an essential source...

December 2010
FROM

Oncolytics Biotech Inc. (ONC) - Financial and Strategic SWOT Analysis Review

Oncolytics Biotech Inc. (ONC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

May 2014
FROM

Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020” The report is an...

November 2010
FROM

Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Brazil, Russia, India and China (BRIC) Drug Forecasts and Treatment Analysis...

December 2010
FROM

Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020” is an essential source of information...

November 2010
FROM

Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020” is an essential source of information...

December 2010
FROM

Brain Metastasis - Pipeline Review, H1 2014

Brain Metastasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Brain Metastasis - Pipeline Review, H1 2014’, provides an overview of the Brain Metastasis’s therapeutic pipeline. This...

February 2014
FROM

Essential Thrombocythemia - Pipeline Review, H1 2014

Essential Thrombocythemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Essential Thrombocythemia - Pipeline Review, H1 2014’, provides an overview of the Essential Thrombocythemia’s...

February 2014
FROM

Essential Thrombocythemia - Pipeline Review, H2 2014

Essential Thrombocythemia - Pipeline Review, H2 2014 Summary This, ‘Essential Thrombocythemia - Pipeline Review, H2 2014’, provides an overview of the Essential Thrombocythemia’s therapeutic pipeline. This...

July 2014
FROM

The Emerging Cancer Vaccine Market, 2nd Edition

Propelled by advances in molecular biology, the cancer vaccine industry is poised for unprecedented growth. This second edition of Kalorama’s groundbreaking 2003 study completely updates the market...

November 2006
FROM
Loading Indicator

Our Clients

Procter & Gamble Co. Western Union Company Volvo Car Corporation Morgan Stanley SAP SE LG Corporation Roche Diagnostics Ltd.